drug

STRO-004

1 story · latest Aug 12, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Sutro Biopharma, Inc.

Timeline

Sutro Biopharma posts early STRO-004 responses, updates Q2 2026 financials

Aug 12Clinical readoutSTRO-004 Sutro Biopharma, Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.